Oriental Research AlliaNce of Acute Ischemic Stroke Given Endovascular Treatment

Record History

See every version on ClinicalTrials.gov ↗

1. Minor Jul 10, 2023 Interventions: in situ ischemic postconditioning (ISIPC) (Procedure) to rapid local ischemic postconditioning (RL-IPostC) (Procedure)v7
2. Notable Jun 22, 2023 Enrollment target: 80 to 160v6
3. Notable Jun 18, 2023 Enrollment target: 1000 to 80v5 Show 6 more changesShow less

   • Primary endpoint revised
   • Interventions: Endovascular intervention (Procedure) to in situ ischemic postconditioning (ISIPC) (Procedure)
   • Eligibility criteria shortened, about 122 words
   • Secondary endpoints: 3 to 6
   • Study description shortened, about 77 words
   • Collaborators: 6 to 1
4. Notable May 1, 2023 Start date: Oct 1, 2021 to Jan 1, 2022v4 Show 5 more changesShow less

   • Trial status: Enrolling by Invitation to Recruiting
   • Study sites: 1 to 2
   • Interventions: Endovascular intervention (Procedure)
   • Study description expanded, about 130 words
   • Collaborators: 5 to 6
5. Minor Nov 10, 2021 Start date changed from estimate of Sep 2021 to Oct 1, 2021v3
6. Notable Aug 28, 2021 Primary endpoint revised

   • Eligibility criteria expanded, about 27 words
   • Secondary endpoints revised (3)

   v2
7. Minor Aug 22, 2021 Study First Submitted

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.